Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
  • For Authors
    • Call for Papers
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
  • For Authors
    • Call for Papers
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
CEBP Focus: Multilevel Approaches to Addressing Cancer Health Disparities

The New Vital Sign: Where Do You Live?

Electra D. Paskett
Electra D. Paskett
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: electra.paskett@osumc.edu
DOI: 10.1158/1055-9965.EPI-16-0146 Published April 2016
  • Article
  • Info & Metrics
  • PDF
Loading

It is widely accepted that differences in risk factors, incidence, mortality, or stage of disease among populations, collectively known as health disparities, should not exist. Populations that experience disparities include racial/ethnic minorities, rural, and inner city residents, those of low socioeconomic status (SES), and LGBT groups (1). It is clear that health disparities need to be addressed to reduce the burden of cancer in the population as a whole.

Populations that experience cancer health disparities often live in defined, segregated geographic areas that have in common features that promote disparities rather than facilitate reductions in disparities in cancer outcomes. For example, lower SES areas frequently have a higher per capita burden of stores that sell tobacco products and display tobacco advertising (2). The rural area of Appalachia, Ohio, where I conduct most of my research, has (i) counties without a grocery store to purchase fresh meat, vegetables, and fruit; (ii) fewer sidewalks and health clubs to engage in exercise; (iii) counties with one or no mammography facilities; (iv) fewer colonoscopy facilities; (v) no public transportation; and (vi) poor access to state-of-the-art treatment facilities. In metropolitan Chicago, women who reside in low SES neighborhoods do not have access to quality breast cancer screening and treatment facilities (3).

In all of these situations, the impact of living in unfavorable geospatial factors is the same: poorer cancer outcomes. Moreover, residence is a marker for poorer adherence to medical advice. For example, those who live in poorer areas are less likely to stop smoking (4, 5) and find it harder to travel to a quality facility for a screening test (6). Thus, where one lives is a risk factor for disease and mortality above the usual risk factors.

Asking a patient “where do you live?” could be used to identify geographic exposures associated with cancer risk and outcomes. As there are well-defined thresholds for other vital signs, such as high blood pressure, thresholds for geographic areas could be developed and programmed into electronic medical records (EMR). There are many scales developed to assess neighborhood SES, such as the RAND N-SES (7, 8) or even the U.S. government definition of economically “distressed” and “at-risk” counties (9) that could be used to identify high-risk neighborhoods. Research needs to be conducted to construct or select a measure that could easily be implemented within an EMR, and clinicians could easily obtain a “value” for a patient with “risk” defined. As with accepted vital signs like blood pressure, this measure would need to have meaning and value in terms of predicting disease risk status. Moreover, this metric should be easy to assess and interpret and be easily reproducible.

What could a health care provider do if they learn their patient lives in a “high risk” geographical area? One answer is found in the unfunded mandate in the Affordable Care Act for patient navigators. Patient navigation, first coined by Dr. Harold Freeman (10), has demonstrated the ability to improve screening uptake (11, 12), follow-up of abnormalities (13, 14), and receipt of prompt and proper care (15, 16). Navigation works, but it is not correctly or widely implemented. With limited resources, a navigator could be assigned to assist a patient with a “vital sign” that indicates they live in a high-risk geographic area. In addition, specialized navigators could be used as community health workers to go into high-risk geographic areas to educate and direct residents to appropriate care facilities to mitigate risk for poor cancer outcomes. The time has come to accept that where we live impacts our health and do something to mitigate risks associated with living in an unfavorable neighborhood.

See all articles in this CEBP Focus section, “Multilevel Approaches to Addressing Cancer Health Disparities.”

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

  • Received February 10, 2016.
  • Accepted February 11, 2016.
  • ©2016 American Association for Cancer Research.

References

  1. 1.↵
    Centers for Disease Control and Prevention. CDC health disparities and inequalities report - United States, 2013; 2013. Available from: http://www.cdc.gov/mmwr/pdf/other/su6203.pdf.
  2. 2.↵
    1. Lee JG,
    2. Henriksen L,
    3. Rose SW,
    4. Moreland-Russell S,
    5. Ribisl KM
    . A systematic review of neighborhood disparities in point-of-sale tobacco marketing. Am J Public Health 2015;105:e8–18.
    OpenUrlCrossRef
  3. 3.↵
    1. Mortel M,
    2. Rauscher GH,
    3. Murphy AM,
    4. Hoskins K,
    5. Warnecke RB
    . Racial and ethnic disparity in symptomatic breast cancer awareness despite a recent screen: the role of tumor biology and mammography facility characteristics. Cancer Epidemiol Biomarkers Prev 2015;24:1599–606.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Barbeau EM,
    2. Krieger N,
    3. Soobader MJ
    . Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am J Public Health 2004;94:269–78.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Barbeau EM,
    2. Leavy-Sperounis A,
    3. Balbach ED
    . Smoking, social class, and gender: what can public health learn from the tobacco industry about disparities in smoking? Tob Control 2004;13:115–20.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Peipins LA,
    2. Graham S,
    3. Young R,
    4. Lewis B,
    5. Foster S,
    6. Flanagan B,
    7. et al.
    Time and distance barriers to mammography facilities in the Atlanta metropolitan area. J Community Health 2011;36:675–83.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Dubowitz T,
    2. Heron M,
    3. Bird CE,
    4. Lurie N,
    5. Finch BK,
    6. Basurto-Davila R,
    7. et al.
    Neighborhood socioeconomic status and fruit and vegetable intake among whites, blacks, and Mexican Americans in the United States. Am J Clin Nutr 2008;87:1883–91.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Merkin SS,
    2. Basurto-Davila R,
    3. Karlamangla A,
    4. Bird CE,
    5. Lurie N,
    6. Escarce J,
    7. et al.
    Neighborhoods and cumulative biological risk profiles by race/ethnicity in a national sample of U.S. adults: NHANES III. Ann Epidemiol 2009;19:194–201.
    OpenUrlCrossRefPubMed
  9. 9.↵
    US Department of Commerce, Economic Development Administration. The code of federal regulations of the United States of America; 2007. Available from: https://www.eda.gov/pdf/EDAs_regs-13_CFR_Chapter_III.pdf.
  10. 10.↵
    1. Freeman HP,
    2. Muth BJ,
    3. Kerner JF
    . Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 1995;3:19–30.
    OpenUrlPubMed
  11. 11.↵
    1. Burhansstipanov L,
    2. Dignan MB,
    3. Schumacher A,
    4. Krebs LU,
    5. Alfonsi G,
    6. Apodaca CC
    . Breast screening navigator programs within three settings that assist underserved women. J Cancer Educ 2010;25:247–52.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Wang X,
    2. Fang C,
    3. Tan Y,
    4. Liu A,
    5. Ma GX
    . Evidence-based intervention to reduce access barriers to cervical cancer screening among underserved Chinese American women. J Womens Health 2010;19:463–9.
    OpenUrlCrossRef
  13. 13.↵
    1. Battaglia TA,
    2. Bak SM,
    3. Heeren T,
    4. Chen CA,
    5. Kalish R,
    6. Tringale S,
    7. et al.
    Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomarkers Prev 2012;21:1645–54.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Hoffman HJ,
    2. LaVerda NL,
    3. Young HA,
    4. Levine PH,
    5. Alexander LM,
    6. Brem R,
    7. et al.
    Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. Cancer Epidemiol Biomarkers Prev 2012;21:1655–63.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Luckett R,
    2. Pena N,
    3. Vitonis A,
    4. Bernstein MR,
    5. Feldman S
    . Effect of patient navigator program on no-show rates at an academic referral colposcopy clinic. J Womens Health 2015;24:608–15.
    OpenUrl
  16. 16.↵
    1. Percac-Lima S,
    2. Benner CS,
    3. Lui R,
    4. Aldrich LS,
    5. Oo SA,
    6. Regan N,
    7. et al.
    The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women. J Womens Health 2013;22:426–31.
    OpenUrlCrossRef
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 25 (4)
April 2016
Volume 25, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The New Vital Sign: Where Do You Live?
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
Citation Tools
The New Vital Sign: Where Do You Live?
Electra D. Paskett
Cancer Epidemiol Biomarkers Prev April 1 2016 (25) (4) 581-582; DOI: 10.1158/1055-9965.EPI-16-0146

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The New Vital Sign: Where Do You Live?
Electra D. Paskett
Cancer Epidemiol Biomarkers Prev April 1 2016 (25) (4) 581-582; DOI: 10.1158/1055-9965.EPI-16-0146
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Disclosure of Potential Conflicts of Interest
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Health Disparities in Local Print News
  • Multilevel Screening Mammography Intervention for Latinas
Show more CEBP Focus: Multilevel Approaches to Addressing Cancer Health Disparities
  • Home
  • Alerts
  • Feedback
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement